UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2004
ATS MEDICAL, INC.
-----------------
(Exact name of registrant as specified in its charter)
Minnesota 0-18602 41-1595629
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission file number) (I.R.S. Employer
of incorporation) Identification No.)
3905 Annapolis Lane N., Minneapolis, Minnesota 55447
----------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (763) 553-7736
--------------
Not Applicable
--------------
(Former name or former address, if changed since last report)
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) The following exhibit is being "furnished" in accordance with Item 12
of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing:
99.1 Press Release, dated April 29, 2004, of ATS Medical, Inc.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION FOR A COMPLETED QUARTER
The following information is being "furnished" in accordance with Item 12 of
Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing:
On April 29, 2004, ATS Medical, Inc. issued a press release to report
the Company's results of operations and financial condition for the
completed fiscal quarter ended March 31, 2004. The release is furnished
as Exhibit 99.1 hereto and is incorporated herein by reference.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
April 29, 2004 ATS MEDICAL, INC.
By: /s/ John R. Judd
----------------
John R. Judd
Chief Financial Officer
-3-
EXHIBIT INDEX
99.1 Press Release, dated April 29, 2004, of ATS Medical, Inc.